BullFrog AI collaboration with LIBD identifies bipolar disorder molecular pathways, potential drug targets

BullFrog AI Holdings, Inc.

Six of 68 gene clusters from LIBD brain dataset significantly enriched, pinpointing gene networks involved in bipolar disorder.
Notable findings in Dentate Gyrus (memory/cognition) and Dorsolateral Prefrontal Cortex (executive function).
Analysis suggests dysregulation of pro-inflammatory pathways; novel pathways and putative drivers identified.
Company engaging with pharmaceutical partners for drug target discovery deals.
BullFrog AI used its bfLEAP platform and causal AI strategy in collaboration with LIBD.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.